It’s admittedly less than high times at listed pot stock Creso Pharma, from whose board EverBlu Capital’s Adam Blumenthal this month resigned, having previously stepped aside as Creso chairman last November after a series of raids by the Australian Federal Police.

Those raids, conducted on behalf of the corporate regulator, were last week revealed by this newspaper to have arisen from suspicions Blumenthal and EverBlu may have rigged trading in Creso shares alongside Tyson ”ASX Wolf” Scholz. No proceedings have been issued against Blumenthal or EverBlu.